{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:45:22Z","timestamp":1758127522450},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,6,6]]},"abstract":"<jats:p>This Medical News article discusses research presented at the recent American Academy of Neurology Conference.<\/jats:p>","DOI":"10.1001\/jama.2023.4389","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T15:08:17Z","timestamp":1683731297000},"page":"1811","source":"Crossref","is-referenced-by-count":1,"title":["New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines\u2014Highlights From the 2023 American Academy of Neurology Conference"],"prefix":"10.1001","volume":"329","author":[{"given":"Revital","family":"Marcus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2804989\/jama_marcus_2023_mn_230023_1685658865.3592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:00:35Z","timestamp":1686074435000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2804989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":0,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,6,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.4389","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,6]]}}}